Beyond wavy hairs: The epidermal growth factor receptor and its ligands in skin biology and pathology

American Journal of Pathology

Volumn 173, Issue 1, 2008, Pages 14-24

  Schneider, Marlon R ^a   Werner, Sabine ^c   Paus, Ralf ^b,d   Wolf, Eckhard ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c ETH ZURICH   (Switzerland)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIREGULIN; TRANSFORMING GROWTH FACTOR ALPHA;

CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; HAIR FOLLICLE; HOMEOSTASIS; MORPHOGENESIS; MUTATION; PHENOTYPE; PRIORITY JOURNAL; PSORIASIS; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SIGNAL PROCESSING; SKIN; WOUND HEALING;

EID: 46749122327     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.070942     Document Type: Review

References (120)

1. Crew FAE: Waved: an autosomal recessive coat form character in the mouse. J Genet 1933, 27:95-96
2. Keeler CE: A second rexoid coat character in the house mouse. J Hered 1935, 26:189-191
3. Luetteke NC, Phillips HK, Qiu TH, Copeland NG, Earp HS, Jenkins NA, Lee DC: The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev 1994, 8:399-413
4. Fowler KJ, Walker F, Alexander W, Hibbs ML, Nice EC, Bohmer RM, Mann GB, Thumwood C, Maglitto R, Danks JA, Chetty R, Burgess AW, Dunn AR: A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation. Proc Natl Acad Sci USA 1995, 92:1465-1469
5. Coffey RJ Jr, Derynck R, Wilcox JN, Bringman TS, Goustin AS, Moses HL, Pittelkow MR: Production and auto-induction of transforming growth factor-alpha in human keratinocytes. Nature 1987, 328: 817-820
6. Cook PW, Mattox PA, Keeble WW, Pittelkow MR, Plowman GD, Shoyab M, Adelman JP, Shipley GD: A heparin sulfate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin. Mol Cell Biol 1991, 11:2547-2557
7. Hashimoto K, Higashiyama S, Asada H, Hashimura E, Kobayashi T, Sudo K, Nakagawa T, Damm D, Yoshikawa K, Taniguchi N: Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. J Biol Chem 1994, 269:20060-20066
8. Stoll S, Garner W, Elder J: Heparin-binding ligands mediate autocrine epidermal growth factor receptor activation in skin organ culture. J Clin Invest 1997, 100:1271-1281
9. Piepkorn M, Pittelkow MR, Cook PW: Autocrine regulation of keratinocytes: the emerging role of heparin-binding, epidermal growth factor-related growth factors. J Invest Dermatol 1998, 111:715-721
10. Shirakata Y, Komurasaki T, Toyoda H, Hanakawa Y, Yamasaki K, Tokumaru S, Sayama K, Hashimoto K: Epiregulin, a novel member of the epidermal growth factor family, is an autocrine growth factor in normal human keratinocytes. J Biol Chem 2000, 275:5748-5753
11. Traxler P, Allegrini PR, Brandt R, Brueggen J, Cozens R, Fabbro D, Grosios K, Lane HA, McSheehy P, Mestan J, Meyer T, Tang C, Wartmann M, Wood J, Caravatti G: AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity. Cancer Res 2004, 64:4931-4941
12. Amin DN, Hida K, Bielenberg DR, Klagsbrun M: Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors. Cancer Res 2006, 66:2173-2180
13. Grotendorst GR, Soma Y, Takehara K, Charette M: EGF and TGF-alpha are potent chemoattractants for endothelial cells and EGF-like peptides are present at sites of tissue regeneration. J Cell Physiol 1989, 139:617-623
14. Marikovsky M, Breuing K, Liu PY, Eriksson E, Higashiyama S, Farber P, Abraham J, Klagsbrun M: Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc Natl Acad Sci USA 1993, 90:3889-3893
15. Ono I, Gunji H, Zhang JZ, Maruyama K, Kaneko F: Studies on cytokines related to wound healing in donor site wound fluid. J Dermatol Sci 1995, 10:241-245
16. Stoscheck CM, Nanney LB, King LE Jr: Quantitative determination of EGF-R during epidermal wound healing. J Invest Dermatol 1992, 99:645-649
17. Piepkorn M: Overexpression of amphiregulin, a major autocrine growth factor for cultured human keratinocytes, in hyperproliferative skin diseases. Am J Dermatopathol 1996, 18:165-171
18. Elder JT, Fisher GJ, Lindquist PB, Bennett GL, Pittelkow MR, Coffey RJ Jr, Ellingsworth L, Derynck R, Voorhees JJ: Overexpression of transforming growth factor alpha in psoriatic epidermis. Science 1989, 243:811-814
19. Stoll SW, Elder JT: Retinoid regulation of heparin-binding EGF-like growth factor gene expression in human keratinocytes and skin. Exp Dermatol 1998, 7:391-397
20. Yamamoto T, Kamata N, Kawano H, Shimizu S, Kuroki T, Toyoshima K, Rikimaru K, Nomura N, Ishizaki R, Pastan I, Gamou S, Shimizu N: High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. Cancer Res 1986, 46: 414-416
21. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, Berger WH: Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res 1987, 47:707-712
22. Gordon-Thomson C, Jones J, Mason RS, Moore GP: ErbB receptors mediate both migratory and proliferative activities in human melanocytes and melanoma cells. Melanoma Res 2005, 15:21-28
23. Sibilia M, Fleischmann A, Behrens A, Stingl L, Carroll J, Watt FM, Schlessinger J, Wagner EF: The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development. Cell 2000, 102:211-220
24. Hansen LA, Woodson RL, Holbus S, Strain K, Lo YC, Yuspa SH: The epidermal growth factor receptor is required to maintain the proliferative population in the basal compartment of epidermal tumors. Cancer Res 2000, 60:3328-3332
25. El Abaseri TB, Putta S, Hansen LA: Ultraviolet irradiation induces keratinocyte proliferation and epidermal hyperplasia through the activation of the epidermal growth factor receptor. Carcinogenesis 2006, 27:225-231
26. Rittié L, Kansra S, Stoll SW, Li Y, Gudjonsson JE, Shao Y, Michael LE, Fisher GJ, Johnson TM, Elder JT: Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin. Am J Pathol 2007, 170:2089-2099
27. Sibilia M, Wagner EF: Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 1995, 269:234-238
28. Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, Yee D, LaMantia C, Mourton T, Herrup K, Harris RC, Barnard JA, Yuspa SH, Coffey RJ, Magnuson T: Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 1995, 269: 230-234
29. Miettinen PJ, Berger JE, Meneses J, Phung Y, Pedersen RA, Werb Z, Derynck R: Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 1995, 376:337-341
30. Hansen LA, Alexander N, Hogan ME, Sundberg JP, Dlugosz A, Threadgill DW, Magnuson T, Yuspa SH: Genetically null mice reveal a central role for epidermal growth factor receptor in the differentiation of the hair follicle and normal hair development. Am J Pathol 1997, 150:1959-1975
31. Dlugosz AA, Hansen L, Cheng C, Alexander N, Denning MF, Threadgill DW, Magnuson T, Coffey RJ Jr, Yuspa SH: Targeted disruption of the epidermal growth factor receptor impairs growth of squamous papillomas expressing the v-ras(Ha) oncogene but does not block in vitro keratinocyte responses to oncogenic ras. Cancer Res 1997, 57:3180-3188
32. Sibilia M, Wagner B, Hoebertz A, Elliott C, Marino S, Jochum W, Wagner EF: Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heart. Development 2003, 130:4515-4525
33. Murillas R, Larcher F, Conti CJ, Santos M, Ullrich A, Jorcano JL: Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure. EMBO J 1995, 14: 5216-5223
34. Bol D, Kiguchi K, Beltran L, Rupp T, Moats S, Gimenez-Conti I, Jorcano J, Digiovanni J: Severe follicular hyperplasia and spontaneous papilloma formation in transgenic mice expressing the neu oncogene under the control of the bovine keratin 5 promoter. Mol Carcinog 1998, 21:2-12
35. Kiguchi K, Bol D, Carbajal S, Beltran L, Moats S, Chan K, Jorcano J, Digiovanni J: Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development. Oncogene 2000, 19:4243-4254
36. Xie W, Wu X, Chow LT, Chin E, Paterson AJ, Kudlow JE: Targeted expression of activated erbB-2 to the epidermis of transgenic mice elicits striking developmental abnormalities in the epidermis and hair follicles. Cell Growth Differ 1998, 9:313-325
37. Xie W, Chow LT, Paterson AJ, Chin E, Kudlow JE: Conditional expression of the ErbB2 oncogene elicits reversible hyperplasia in stratified epithelia and up-regulation of TGFalpha expression in transgenic mice. Oncogene 1999, 18:3593-3607
38. Cook PW, Piepkorn M, Clegg CH, Plowman GD, DeMay JM, Brown JR, Pittelkow MR: Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype. J Clin Invest 1997, 100:2286-2294
39. Cook PW, Brown JR, Cornell KA, Pittelkow MR: Suprabasal expression of human amphiregulin in the epidermis of transgenic mice induces a severe, early-onset, psoriasis-like skin pathology: expression of amphiregulin in the basal epidermis is also associated with synovitis. Exp Dermatol 2004, 13:347-356
40. Chung E, Cook PW, Parkos CA, Park YK, Pittelkow MR, Coffey RJ: Amphiregulin causes functional downregulation of adherens junctions in psoriasis. J Invest Dermatol 2005, 124:1134-1140
41. Schneider MR, Antsiferova M, Feldmeyer L, Dahlhoff M, Bugnon P, Hasse S, Paus R, Wolf E, Werner S: Betacellulin regulates hair follicle development and hair cycle induction and enhances angiogenesis in wounded skin. J Invest Dermatol 2008, 128:1256-1265
42. Mak KK, Chan SY: Epidermal growth factor as a biologic switch in hair growth cycle. J Biol Chem 2003, 278:26120-26126
43. Shirasawa S, Sugiyama S, Baba I, Inokuchi J, Sekine S, Ogino K, Kawamura Y, Dohi T, Fujimoto M, Sasazuki T: Dermatitis due to epiregulin deficiency and a critical role of epiregulin in immune-related responses of keratinocyte and macrophage. Proc Natl Acad Sci USA 2004, 101:13921-13926
44. Shirakata Y, Kimura R, Nanba D, Iwamoto R, Tokumaru S, Morimoto C, Yokota K, Nakamura M, Sayama K, Mekada E, Higashiyama S, Hashimoto K: Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing. J Cell Sci 2005, 118:2363-2370
45. Luetteke NC, Qiu TH, Peiffer RL, Oliver P, Smithies O, Lee DC: TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell 1993, 73:263-278
46. Mann GB, Fowler KJ, Gabriel A, Nice EC, Williams RL, Dunn AR: Mice with a null mutation of the TGF alpha gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell 1993, 73:249-261
47. Kim I, Mogford JE, Chao JD, Mustoe TA: Wound epithelialization deficits in the transforming growth factor-alpha knockout mouse. Wound Repair Regen 2001, 9:386-390
48. Jhappan C, Takayama H, Dickson RB, Merlino G: Transgenic mice provide genetic evidence that transforming growth factor alpha promotes skin tumorigenesis via H-ras-dependent and H-ras-independent pathways. Cell Growth Differ 1994, 5:385-394
49. Shibata MA, Ward JM, Green JE, Merlino G: Enhanced sensitivity to tumor growth and development in multistage skin carcinogenesis by transforming growth factor-alpha-induced epidermal growth factor receptor activation but not p53 inactivation. Mol Carcinog 1997, 18:160-170
50. Vassar R, Fuchs E: Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation. Genes Dev 1991, 5:714-727
51. Vassar R, Hutton ME, Fuchs E: Transgenic overexpression of transforming growth factor alpha bypasses the need for c-Ha-ras mutations in mouse skin tumorigenesis. Mol Cell Biol 1992, 12:4643-4653
52. Dominey AM, Wang XJ, King LE Jr, Nanney LB, Gagne TA, Sellheyer K, Bundman DS, Longley MA, Rothnagel JA, Greenhalgh DA: Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas. Cell Growth Differ 1993, 4:1071-1082
53. Wang XJ, Greenhalgh DA, Eckhardt JN, Rothnagel JA, Roop DR: Epidermal expression of transforming growth factor-alpha in transgenic mice: induction of spontaneous and 12-O-tetradecanoylphorbol-13-acetate-induced papillomas via a mechanism independent of Ha-ras activation or overexpression. Mol Carcinog 1994, 10:15-22
54. Wang XJ, Greenhalgh DA, Lu XR, Bickenbach JR, Roop DR: TGF alpha and v-fos cooperation in transgenic mouse epidermis induces aberrant keratinocyte differentiation and stable, autonomous papillomas. Oncogene 1995, 10:279-289
55. Wang XJ, Liefer KM, Greenhalgh DA, Roop DR: 12-O-tetradecanoylphorbol-13- acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation. Mol Carcinog 1999, 26:305-311
56. Wang XJ, Greenhalgh DA, Roop DR: Transgenic coexpression of v-Ha-ras and transforming growth factor alpha increases epidermal hyperproliferation and tumorigenesis and predisposes to malignant conversion via endogenous c-Ha-ras activation. Mol Carcinog 2000, 27:200-209
57. Wang XJ, Greenhalgh DA, Donehower LA, Roop DR: Cooperation between Ha-ras and fos or transforming growth factor alpha overcomes a paradoxic tumor-inhibitory effect of p53 loss in transgenic mouse epidermis. Mol Carcinog 2000, 29:67-75
58. Holbro T, Hynes NE: ErbB receptors: directing key signaling networks throughout life. Annu Rev Pharmacol Toxicol 2004, 44:195-217
59. Zandi R, Larsen AB, Andersen P, Stockhausen MT, Poulsen HS: Mechanisms for oncogenic activation of the epidermal growth factor receptor. Cell Signal 2007, 19:2013-2023
60. Yarden Y, Sliwkowski MX: Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001, 2:127-137
61. Citri A, Yarden Y: EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol 2006, 7:505-516
62. Kochupurakkal BS, Harari D, Di Segni A, Maik-Rachline G, Lyass L, Gur G, Kerber G, Citri A, Lavi S, Eilam R, Chalifa-Caspi V, Eshhar Z, Pikarsky E, Pinkas-Kramarski R, Bacus SS, Yarden Y: Epigen, the last ligand of ErbB receptors, reveals intricate relationships between affinity and mitogenicity. J Biol Chem 2005, 280:8503-8512
63. Harris RC, Chung E, Coffey RJ: EGF receptor ligands. Exp Cell Res 2003, 284:2-13
64. Singh AB, Harris RC: Autocrine, paracrine and juxtacrine signaling by EGFR ligands. Cell Signal 2005, 17:1183-1193
65. Pastore S, Mascia F, Mariani V, Girolomoni G: The epidermal growth factor receptor system in skin repair and inflammation. J Invest Dermatol 2008, 128:1365-1374
66. Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, Carotenuto A, De Feo G, Caponigro F, Salomon DS: Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 2006, 366:2-16
67. Yarden Y, Shilo BZ: SnapShot: EGFR signaling pathway. Cell 2007, 131:1018
68. Waterman H, Yarden Y: Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases. FEBS Lett 2001, 490:142-152
69. Klapper LN, Glathe S, Vaisman N, Hynes NE, Andrews GC, Sela M, Yarden Y: The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors. Proc Natl Acad Sci USA 1999, 96:4995-5000
70. Guy PM, Platko JV, Cantley LC, Cerione RA, Carraway KL III: Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity. Proc Natl Acad Sci USA 1994, 91:8132-8136
71. Citri A, Skaria KB, Yarden Y: The deaf and the dumb: the biology of ErbB-2 and ErbB-3. Exp Cell Res 2003, 284:54-65
72. Carpenter G: Employment of the epidermal growth factor receptor in growth factor-independent signaling pathways. J Cell Biol 1999, 146:697-702
73. Lee KF, Simon H, Chen H, Bates B, Hung MC, Hauser C: Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 1995, 378:394-398
74. Riethmacher D, Sonnenberg-Riethmacher E, Brinkmann V, Yamaai T, Lewin GR, Birchmeier C: Severe neuropathies in mice with targeted mutations in the ErbB3 receptor. Nature 1997, 389:725-730
75. Gassmann M, Casagranda F, Orioli D, Simon H, Lai C, Klein R, Lemke G: Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 1995, 378:390-394
76. Green MR, Basketter DA, Couchman JR, Rees DA: Distribution and number of epidermal growth factor receptors in skin is related to epithelial cell growth. Dev Biol 1983, 100:506-512
77. Nanney LB, Magid M, Stoscheck CM, King LE Jr: Comparison of epidermal growth factor binding and receptor distribution in normal human epidermis and epidermal appendages. J Invest Dermatol 1984, 83:385-393
78. Peus D, Hamacher L, Pittelkow MR: EGF-receptor tyrosine kinase inhibition induces keratinocyte growth arrest and terminal differentiation. J Invest Dermatol 1997, 109:751-756
79. Stoll SW, Kansra S, Peshick S, Fry DW, Leopold WR, Wiesen JF, Sibilia M, Zhang T, Werb Z, Derynck R, Wagner EF, Elder JT: Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes. Neoplasia 2001, 3:339-350
80. Lee D, Cross SH, Strunk KE, Morgan JE, Bailey CL, Jackson IJ, Threadgill DW: Wa5 is a novel ENU-induced antimorphic allele of the epidermal growth factor receptor. Mamm Genome 2004, 15:525-536
81. Du X, Tabeta K, Hoebe K, Liu H, Mann N, Mudd S, Crozat K, Sovath S, Gong X, Beutler B: Velvet, a dominant Egfr mutation that causes wavy hair and defective eyelid development in mice. Genetics 2004, 166:331-340
82. Fitch KR, McGowan KA, van Raamsdonk CD, Fuchs H, Lee D, Puech A, Herault Y, Threadgill DW, Hrabe DA, Barsh GS: Genetics of dark skin in mice. Genes Dev 2003, 17:214-228
83. Hansen LA, Lichti U, Tennenbaum T, Dlugosz A, Threadgill DW, Magnuson T, Yuspa SH: Altered hair follicle morphogenesis in epidermal growth factor receptor deficient mice. Hair research for the next millennium. Edited by DJJ Van Neste and VA Randall. Amsterdam, Elsevier, 1996, pp 425-431
84. Kokai Y, Cohen JA, Drebin JA, Greene MI: Stage- and tissue-specific expression of the neu oncogene in rat development. Proc Natl Acad Sci USA 1987, 84:8498-8501
85. Quirke P, Pickles A, Tuzi NL, Mohamdee O, Gullick WJ: Pattern of expression of c-erbB-2 oncoprotein in human fetuses. Br J Cancer 1989, 60:64-69
86. Maguire HC Jr, Jaworsky C, Cohen JA, Hellman M, Weiner DB, Greene MI: Distribution of neu (c-erbB-2) protein in human skin. J Invest Dermatol 1989, 92:786-790
87. Xian W, Rosenberg MP, Digiovanni J: Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion. Oncogene 1997, 14:1435-1444
88. Madson JG, Lynch DT, Tinkum KL, Putta SK, Hansen LA: Erbb2 regulates inflammation and proliferation in the skin after ultraviolet irradiation. Am J Pathol 2006, 169:1402-1414
89. Piepkorn M, Predd H, Underwood R, Cook P: Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes. Arch Dermatol Res 2003, 295:93-101
90. Okwueze MI, Cardwell NL, Pollins AC, Nanney LB: Modulation of porcine wound repair with a transfected ErbB3 gene and relevant EGF-like ligands. J Invest Dermatol 2007, 127:1030-1041
91. Rittie L, Varani J, Kang S, Voorhees JJ, Fisher GJ: Retinoid-induced epidermal hyperplasia is mediated by epidermal growth factor receptor activation via specific induction of its ligands heparin-binding EGF and amphiregulin in human skin in vivo. J Invest Dermatol 2006, 126:732-739
92. Cook PW, Pittelkow MR, Keeble WW, Graves-Deal R, Coffey RJ Jr, Shipley GD: Amphiregulin messenger RNA is elevated in psoriatic epidermis and gastrointestinal carcinomas. Cancer Res 1992, 52:3224-3227
93. Luetteke NC, Qiu TH, Fenton SE, Troyer KL, Riedel RF, Chang A, Lee DC: Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 1999, 126:2739-2750
94. Bhagavathula N, Nerusu KC, Fisher GJ, Liu G, Thakur AB, Gemmell L, Kumar S, Xu ZH, Hinton P, Tsurushita N, Landolfi NF, Voorhees JJ, Varani J: Amphiregulin and epidermal hyperplasia: amphiregulin is required to maintain the psoriatic phenotype of human skin grafts on severe combined immunodeficient mice. Am J Pathol 2005, 166:1009-1016
95. Jackson LF, Qiu TH, Sunnarborg SW, Chang A, Zhang C, Patterson C, Lee DC: Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J 2003, 22: 2704-2716
96. Moore GP, Panaretto BA, Robertson D: Epidermal growth factor delays the development of the epidermis and hair follicles of mice during growth of the first coat. Anat Rec 1983, 205:47-55
97. Moore GP, Panaretto BA, Robertson D: Inhibition of wool growth in merino sheep following administration of mouse epidermal growth factor and a derivative. Aust J Biol Sci 1982, 35:163-172
98. du Cros DL, Isaacs K, Moore GP: Localization of epidermal growth factor immunoreactivity in sheep skin during wool follicle development. J Invest Dermatol 1992, 98:109-115
99. Sakai Y, Nelson KG, Snedeker S, Bossert NL, Walker MP, McLachlan J, DiAugustine RP: Expression of epidermal growth factor in suprabasal cells of stratified squamous epithelia: implications for a role in differentiation. Cell Growth Differ 1994, 5:527-535
100. Philpott MP, Kealey T: Effects of EGF on the morphology and patterns of DNA synthesis in isolated human hair follicles. J Invest Dermatol 1994, 102:186-191
101. Strachan L, Murison JG, Prestidge RL, Sleeman MA, Watson JD, Kumble KD: Cloning and biological activity of epigen, a novel member of the epidermal growth factor superfamily. J Biol Chem 2001, 276:18265-18271
102. Lee D, Pearsall RS, Das S, Dey SK, Godfrey VL, Threadgill DW: Epiregulin is not essential for development of intestinal tumors but is required for protection from intestinal damage. Mol Cell Biol 2004, 24:8907-8916
103. McCarthy DW, Downing MT, Brigstock DR, Luquette MH, Brown KD, Abad MS, Besner GE: Production of heparin-binding epidermal growth factor-like growth factor (HB-EGF) at sites of thermal injury in pediatric patients. J Invest Dermatol 1996, 106:49-56
104. Ellis PD, Hadfield KM, Pascall JC, Brown KD: Heparin-binding epidermal-growth-factor-like growth factor gene expression is induced by scrape-wounding epithelial cell monolayers: involvement of mitogen-activated protein kinase cascades. Biochem J 2001, 354:99-106
105. Cribbs RK, Harding PA, Luquette MH, Besner GE: Endogenous production of heparin-binding EGF-like growth factor during murine partial-thickness burn wound healing. J Burn Care Rehabil 2002, 23:116-125
106. Xiao JH, Feng X, Di W, Peng ZH, Li LA, Chambon P, Voorhees JJ: Identification of heparin-binding EGF-like growth factor as a target in intercellular regulation of epidermal basal cell growth by suprabasal retinoic acid receptors. EMBO J 1999, 18:1539-1548
107. Varani J, Zeigler M, Dame MK, Kang S, Fisher GJ, Voorhees JJ, Stoll SW, Elder JT: Heparin-binding epidermal-growth-factor-like growth factor activation of keratinocyte ErbB receptors mediates epidermal hyperplasia, a prominent side-effect of retinoid therapy. J Invest Dermatol 2001, 117:1335-1341
108. Iwamoto R, Yamazaki S, Asakura M, Takashima S, Hasuwa H, Miyado K, Adachi S, Kitakaze M, Hashimoto K, Raab G, Nanba D, Higashiyama S, Hori M, Klagsbrun M, Mekada E: Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc Natl Acad Sci USA 2003, 100:3221-3226
109. Yamazaki S, Iwamoto R, Saeki K, Asakura M, Takashima S, Yamazaki A, Kimura R, Mizushima H, Moribe H, Higashiyama S, Endoh M, Kaneda Y, Takagi S, Itami S, Takeda N, Yamada G, Mekada E: Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities. J Cell Biol 2003, 163:469-475
110. Finzi E, Harkins R, Horn T: TGF-alpha is widely expressed in differentiated as well as hyperproliferative skin epithelium. J Invest Dermatol 1991, 96:328-332
111. Dlugosz AA, Cheng C, Williams EK, Darwiche N, Dempsey PJ, Mann B, Dunn AR, Coffey RJ Jr, Yuspa SH: Autocrine transforming growth factor alpha is dispensable for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands. Cancer Res 1995, 55:1883-1893
112. Imamoto A, Beltran LM, Digiovanni J: Evidence for autocrine/paracrine growth stimulation by transforming growth factor-alpha during the process of skin tumor promotion. Mol Carcinog 1991, 4:52-60
113. Greenhalgh DA, Wang XJ, Donehower LA, Roop DR: Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha. Cancer Res 1996, 56:4413-4423
114. Humble MC, Szczesniak CJ, Luetteke NC, Spalding JW, Cannon RE, Hansen LA, Lee DC, Tennant RW: TGF alpha is dispensable for skin tumorigenesis in Tg.AC mice. Toxicol Pathol 1998, 26:562-569
115. Schneider MR, Wolf E: The epidermal growth factor receptor and its ligands in female reproduction: insights from rodent models. Cytokine Growth Factor Rev 2008, 19:173-181
116. Park JY, Su YQ, Ariga M, Law E, Jin SL, Conti M: EGF-like growth factors as mediators of LH action in the ovulatory follicle. Science 2004, 303:682-684
117. Qin L, Tamasi J, Raggatt L, Li X, Feyen JH, Lee DC, Dicicco-Bloom E, Partridge NC: Amphiregulin is a novel growth factor involved in normal bone development and in the cellular response to parathyroid hormone stimulation. J Biol Chem 2005, 280:3974-3981
118. Ferby I, Reschke M, Kudlacek O, Knyazev P, Pante G, Amann K, Sommergruber W, Kraut N, Ullrich A, Fassler R, Klein R: Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation. Nat Med 2006, 12:568-573
119. Ballarò C, Ceccarelli S, Tiveron C, Tatangelo L, Salvatore AM, Segatto O, Alema S: Targeted expression of RALT in mouse skin inhibits epidermal growth factor receptor signalling and generates a Waved-like phenotype. EMBO Rep 2005, 6:755-761
120. Peréz-Soler R, Saltz L: Cutaneous adverse effects with HER1/EGFR-targeted agents: is there a silver lining? J Clin Oncol 2005, 23:5235-5246